Kidney cancer: Identification of novel targets for therapy
- 1 January 2006
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 69 (2) , 224-232
- https://doi.org/10.1038/sj.ki.5000065
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaJournal of Clinical Oncology, 2005
- The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 TranslationCell, 2005
- The role of apoptosis in cancer development and treatment responseNature Reviews Cancer, 2005
- Three Molecularly Targeted Drugs Tested in Kidney Cancer Clinical TrialsJNCI Journal of the National Cancer Institute, 2004
- HIF-1α mRNA and protein upregulation involves Rho GTPase expression during hypoxia in renal cell carcinomaJournal of Cell Science, 2003
- Phase II Trial of Thalidomide for Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2002
- THE NATURAL HISTORY OF SMALL RENAL MASSESJournal of Urology, 2000
- INTERLEUKIN-2 BASED IMMUNOTHERAPY FOR METASTATIC RENAL CELL CARCINOMA WITH THE KIDNEY IN PLACEJournal of Urology, 1999
- The Use of the Bosniak Classification System for Renal Cysts and Cystic TumorsJournal of Urology, 1997
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990